Additional file 5: of Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5 QinXing GuoHaiyan WangXiaoning ZhuXueqin YanMing WangXu XuQin ShiJianbo LuEryi ChenWantao ZhangJianjun 2019 Table S5. Relationship between plasma exosomal miR-196a level and clinicopathologic features in HNC; Table S6. Cox proportional hazards regression models for estimating overall survival related to Table S5. (DOC 86 kb)